Citation: Yang Liu, Yan Liu, Kaiyin Yang, Zhiruo Zhang, Wenbo Zhang, Bingyou Yang, Hua Li, Lixia Chen. A selective HK2 degrader suppresses SW480 cancer cell growth by degrading HK2[J]. Chinese Chemical Letters, ;2024, 35(8): 109264. doi: 10.1016/j.cclet.2023.109264 shu

A selective HK2 degrader suppresses SW480 cancer cell growth by degrading HK2

Yang Liu ^{a, 1} ,
Yan Liu ^{b, 1} ,
Kaiyin Yang ^{d, 1} ,
Zhiruo Zhang ^a ,
Wenbo Zhang ^a ,
Bingyou Yang ^{b, *,} ,
Hua Li ^{a, c, *,} ,
Lixia Chen ^{a, *,}

a.
Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China
b.
Key Laboratory of Basic and Application Research of Beiyao, Ministry of Education, Heilongjiang University of Chinese Medicine, Harbin 150006, China
c.
Institute of Structural Pharmacology & TCM Chemical Biology, College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China
d.
Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

ybywater@163.com

2022041@fjtcm.edu.cn

syzyclx@163.com

Received Date: 29 August 2023
Revised Date: 29 October 2023
Accepted Date: 30 October 2023
Available Online: 3 November 2023

Figures(4)

Hexokinase 2 (HK2) is the rate-limiting enzyme in the first step of glycolysis, catalyzing glucose to glucose-6-phosphate, and overexpressed in most cancer cells. HK2 also binds to voltage-dependent anion channel (VDAC) to stabilize the mitochondrial outer membrane, which inhibits cancer cell apoptosis. Therefore, HK2 has become a potential target for cancer treatment. Proteolysis targeting chimeras (PROTACs) are hetero-bifunctional molecules that recruit an E3 ubiquitin ligase to a given substrate protein resulting in its targeted degradation. Many potent and specific PROTACs targeting dissimilar targets have been developed. In this study, an HK2 PROTAC, 4H-5P-M, was developed and induced the degradation of HK2 relying on the ubiquitin-proteasome system. It was found that 4H-5P-M as an effective HK2 degrader induced HK2 degradation in a dose- and time-dependent manner and suppressed the growth of SW480 cells. 4H-5P-M selectively induced HK2 degradation at a lower concentration than other hexokinase isozymes. Moreover, it could suppress glycolysis and accelerate the apoptosis of cancer cells. Therefore, it provided a new insight into the development of anti-tumor drugs.
- HK2,
- PROTACs,
- Degrader,
- Anti-tumor,
- SW480
1. [1]
  D. Hanahan, R. Weinberg, Cell 144 (2011) 646–674. doi: 10.1016/j.cell.2011.02.013
2. [2]
  N. Pavlova, C. Thompson, Cell Metab. 23 (2016) 27–47. doi: 10.1016/j.cmet.2015.12.006
3. [3]
  S.P. Mathupala, Y.H. Ko, P.L. Pedersen, Oncogene 25 (2006) 4777–4786. doi: 10.1038/sj.onc.1209603
4. [4]
  A. Magrì, S. Reina, V. Pinto, Front. Chem. 6 (2018) 108. doi: 10.3389/fchem.2018.00108
5. [5]
  F. Xu, J. Yan, Y. Gan, et al., Mol. Ther. Nucl. Acids 18 (2019) 308–319. doi: 10.1016/j.omtn.2019.09.002
6. [6]
  G.Y. Gwak, J.H. Yoon, K.M. Kim, et al., J. Hepatol. 42 (2005) 358–364. doi: 10.1016/j.jhep.2004.11.020
7. [7]
  G.L. Semenza, J. Clin. Investig. 123 (2013) 3664–3671. doi: 10.1172/JCI67230
8. [8]
  K.C. Patra, Q. Wang, P.T. Bhaskar, et al., Cancer Cell 24 (2013) 213–228. doi: 10.1016/j.ccr.2013.06.014
9. [9]
  D. Dewaal, V. Nogueira, A.R. Terry, et al., Nat. Commun. 9 (2018) 446. doi: 10.1038/s41467-017-02733-4
10. [10]
  S.N. Garcia, R.C. Guedes, M.M. Marques, Curr. Med. Chem. 26 (2020) 7285–7322. doi: 10.2174/0929867326666181213092652
11. [11]
  W. Li, M.Z. Zheng, S.P. Wu, et al., J. Exp. Clin. Cancer Res. 36 (2017) 58. doi: 10.1080/15567036.2016.1200166
12. [12]
  M.Z. Zheng, C.R. Wu, K.Y. Yang, et al., Pharmacol. Res. 164 (2021) 105367. doi: 10.1016/j.phrs.2020.105367
13. [13]
  A.C. Lai, C.M. Crews, Nat. Rev. Drug Discov. 16 (2017) 101–114. doi: 10.1038/nrd.2016.211
14. [14]
  Y. Liu, M.Z. Zheng, Z.L. Ma, Chin. Chem. Lett. 34 (2023) 107762. doi: 10.1016/j.cclet.2022.107762
15. [15]
  I. Churcher, J. Med. Chem. 61 (2018) 444–452. doi: 10.1021/acs.jmedchem.7b01272
16. [16]
  X.Y. Li, W.C. Pu, Q.Q. Zheng, et al., Mol. Cancer 21 (2022) 99. doi: 10.1186/s12943-021-01434-3
17. [17]
  L. Khavrutskii, J. Yeh, O. Timofeeva, et al., J. Vis. Exp. 78 (2013) 50541.
18. [18]
  M.Y. Chang, F. Gao, J. Chen, et al., Acta Mater. Med. 1 (2022) 333–342.
19. [19]
  Y.B. Li, J.L. Yang, A. Aguilar, et al., J. Med. Chem. 62 (2019) 448–466. doi: 10.1021/acs.jmedchem.8b00909
20. [20]
  J. Hines, S. Lartigue, H.Q. Dong, et al., Cancer Res. 79 (2019) 251–262. doi: 10.1158/0008-5472.can-18-2918
21. [21]
  Q. Zhao, T. Lan, S. Su, et al., Chem. Commun. 55 (2019) 369–372. doi: 10.1039/c8cc07813k
22. [22]
  M.Z. Zheng, J.H. Huo, X.X. Gu, et al., J. Med. Chem. 64 (2021) 7839–7852. doi: 10.1021/acs.jmedchem.1c00649
1. [1]
  Yang Liu , Jing Liang , Mengzhu Zheng , Haoze Song , Lixia Chen , Hua Li . PD-L1/SHP2 dual PROTACs inhibit melanoma by enhancing T-cell killing activity. Chinese Chemical Letters, 2025, 36(6): 110317-. doi: 10.1016/j.cclet.2024.110317
2. [2]
  Si Ha , Jiacheng Zhu , Hua Xiang , Guoshun Luo . Hydrophobic tag tethering degrader as a promising paradigm of protein degradation: Past, present and future perspectives. Chinese Chemical Letters, 2024, 35(8): 109192-. doi: 10.1016/j.cclet.2023.109192
3. [3]
  Qianyun Ye , Yuanyuan Liang , Yuhe Yuan , Xiaohuan Sun , Liqi Zhu , Xuan Wu , Jie Han , Rong Guo . pH-responsive chiral supramolecular cysteine-Zn²⁺-indocyanine green assemblies for triple-level chirality-specific anti-tumor efficacy. Chinese Chemical Letters, 2025, 36(5): 110432-. doi: 10.1016/j.cclet.2024.110432
4. [4]
  Chanqi Ye , Jia Zhang , Jie Shen , Ruyin Chen , Qiong Li , Peng Zhao , Dong Chen , Jian Ruan . Attractive Pickering emulsion gel loaded with oxaliplatin and lactate dehydrogenase inhibitor increases the anti-tumor effect in hepatocellular carcinoma. Chinese Chemical Letters, 2025, 36(7): 110519-. doi: 10.1016/j.cclet.2024.110519
5. [5]
  Huijuan Zhang , Chenglin Liang , Xinyi Ding , Meng Zhang , Siyu Lu , Lin Hou . Manganese-based nano-delivery system for sensitized anti-tumor immunotherapy via combined autophagy inhibition. Chinese Chemical Letters, 2025, 36(7): 110525-. doi: 10.1016/j.cclet.2024.110525
6. [6]
  Yueying Yang , Huiru Xie , Xinbo Yu , Yang Liu , Hui Wang , Hua Li , Lixia Chen . Design, synthesis and evaluation of the first DYRK1A degrader for promoting the proliferation of pancreatic β-cells. Chinese Chemical Letters, 2024, 35(11): 109570-. doi: 10.1016/j.cclet.2024.109570
7. [7]
  Zhenghua ZHAO , Qin ZHANG , Yufeng LIU , Zifa SHI , Jinzhong GU . Syntheses, crystal structures, catalytic and anti-wear properties of nickel(Ⅱ) and zinc(Ⅱ) coordination polymers based on 5-(2-carboxyphenyl)nicotinic acid. Chinese Journal of Inorganic Chemistry, 2024, 40(3): 621-628. doi: 10.11862/CJIC.20230342
8. [8]
  Chuyu Huang , Zhishan Liu , Linping Zhao , Zuxiao Chen , Rongrong Zheng , Xiaona Rao , Yuxuan Wei , Xin Chen , Shiying Li . Metal-coordinated oxidative stress amplifier to suppress tumor growth combined with M2 macrophage elimination. Chinese Chemical Letters, 2024, 35(12): 109696-. doi: 10.1016/j.cclet.2024.109696
9. [9]
  Shangqian Zhang , Jiaxuan Li , Xuan Hu , Zelong Chen , Junliang Dong , Chenhao Hu , Shuang Chao , Yinghua Lv , Yuxin Pei , Zhichao Pei . H₂S and NIR light-driven nanomotors induce disulfidptosis for targeted anticancer therapy by enhancing disruption of tumor metabolic symbiosis. Chinese Chemical Letters, 2025, 36(1): 110314-. doi: 10.1016/j.cclet.2024.110314
10. [10]
  Yuanyuan Zeng , Fang Liu , Jun Wang , Bianfei Shao , Tao He , Zhongzheng Xiang , Yan Wang , Shunyao Zhu , Tian Yang , Siting Yu , Changyang Gong , Lei Liu . Fisetin micelles precisely exhibit a radiosensitization effect by inhibiting PDGFRβ/STAT1/STAT3/Bcl-2 signaling pathway in tumor. Chinese Chemical Letters, 2025, 36(2): 109734-. doi: 10.1016/j.cclet.2024.109734
11. [11]
  Yulong Shi , Fenbei Chen , Mengyuan Wu , Xin Zhang , Runze Meng , Kun Wang , Yan Wang , Yuheng Mei , Qionglu Duan , Yinghong Li , Rongmei Gao , Yuhuan Li , Hongbin Deng , Jiandong Jiang , Yanxiang Wang , Danqing Song . Chemical construction and anti-HCoV-OC43 evaluation of novel 10,12-disubstituted aloperine derivatives as dual cofactor inhibitors of TMPRSS2 and SR-B1. Chinese Chemical Letters, 2024, 35(5): 108792-. doi: 10.1016/j.cclet.2023.108792
12. [12]
  Hui Peng , Xiao Wang , Weiguo Huang , Shuiyue Yu , Linghang Kong , Qilin Wei , Jialong Zhao , Bingsuo Zou . Efficient tunable visible and near-infrared emission in Sb³⁺/Sm³⁺-codoped Cs₂NaLuCl₆ for near-infrared light-emitting diode, triple-mode fluorescence anti-counterfeiting and information encryption. Chinese Chemical Letters, 2024, 35(11): 109462-. doi: 10.1016/j.cclet.2023.109462
13. [13]
  Haiyang Gu , Xiang Xu . Multicolor hybrid metal halides and anti-counterfeiting. Chinese Journal of Structural Chemistry, 2024, 43(9): 100352-100352. doi: 10.1016/j.cjsc.2024.100352
14. [14]
  Yuanmao Fu , Ziang Wang , Kefan Wu , Feiyang Li , Xian Zhang , Hongyuan Cui , Xiaolin Wang , Hui Guo , Yuezhong Meng . Bio-inspired multifunctional hydrogels with adhesive, anti-bacterial, anti-icing and sensing properties. Chinese Chemical Letters, 2025, 36(7): 110479-. doi: 10.1016/j.cclet.2024.110479
15. [15]
  Wenhao Yan , Shuaiya Xue , Xuerui Zhao , Wei Zhang , Jian Li . Hexagonal boron nitride based slippery liquid infused porous surface with anti-corrosion, anti-contaminant and anti-icing properties for protecting magnesium alloy. Chinese Chemical Letters, 2024, 35(4): 109224-. doi: 10.1016/j.cclet.2023.109224
16. [16]
  Yang Liu , Minglu Li , Jianxun Ding , Xuesi Chen . Glycoengineering-assistant biomineralization for tumor blockade therapy. Chinese Chemical Letters, 2025, 36(5): 110146-. doi: 10.1016/j.cclet.2024.110146
17. [17]
  Fengyun Li , Zerong Pei , Shuting Chen , Gen li , Mengyang Liu , Liqin Ding , Jingbo Liu , Feng Qiu . Multifunctional nano-herb based on tumor microenvironment for enhanced tumor therapy of gambogic acid. Chinese Chemical Letters, 2024, 35(5): 108752-. doi: 10.1016/j.cclet.2023.108752
18. [18]
  Cheng-Zhe Gao , Hao-Ran Jia , Tian-Yu Wang , Xiao-Yu Zhu , Xiaofeng Han , Fu-Gen Wu . A dual drug-loaded tumor vasculature-targeting liposome for tumor vasculature disruption and hypoxia-enhanced chemotherapy. Chinese Chemical Letters, 2025, 36(1): 109840-. doi: 10.1016/j.cclet.2024.109840
19. [19]
  Hu Wu , Ge Cao , Mingyang Liu , Hainan Xu , Meng Li , Hanwei Huang , Yujie Liu , Xu Zhao , Xifeng Qin , Onder Ergonul , Füsun Can , Funan Liu , Zhiqing Pang , Jiaming Zhu . Tumor cell membrane biomimetic liposomes-coated oncolytic viruses to target the homotypic tumor and augment the antitumor efficacy. Chinese Chemical Letters, 2025, 36(7): 110493-. doi: 10.1016/j.cclet.2024.110493
20. [20]
  Xiaohong Wen , Mei Yang , Lie Li , Mingmin Huang , Wei Cui , Suping Li , Haiyan Chen , Chen Li , Qiuping Guo . Enzymatically controlled DNA tetrahedron nanoprobes for specific imaging of ATP in tumor. Chinese Chemical Letters, 2024, 35(8): 109291-. doi: 10.1016/j.cclet.2023.109291

Get Citation

PDF

XML

Metrics

PDF Downloads(2)
Abstract views(1107)
HTML views(22)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142